Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets

Treatment of clinically amyopathic dermatomyositis in adults: a systematic review

(2016) J. Callander et al.   BRITISH JOURNAL OF DERMATOLOGY

Dermatomyositis, polymyositis and immune-mediated necrotising myopathies

(2015) Yue-Bei Luo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change

(2015) C.O. Anyanwu et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment of inflammatory myopathy: emerging therapies and therapeutic targets

(2015) Siamak Moghadam-Kia et al.   Expert Review of Clinical Immunology

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis

(2015) Z. Betteridge et al.   JOURNAL OF INTERNAL MEDICINE

Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis

(2015) David F. Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Rheumatologic Skin Disease

(2015) Andrea Kalus   MEDICAL CLINICS OF NORTH AMERICA

Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort

(2014) Levente Bodoki et al.   AUTOIMMUNITY REVIEWS

The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome

(2014) Jean-Christophe Lega et al.   AUTOIMMUNITY REVIEWS

The clinical features, diagnosis and classification of dermatomyositis

(2014) Luca Iaccarino et al.   JOURNAL OF AUTOIMMUNITY

Auto-anticorps au cours des myosites

(2014) Y. Allenbach et al.   REVUE DE MEDECINE INTERNE

Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ

(2013) David F. Fiorentino et al.   ARTHRITIS AND RHEUMATISM

The diagnostic utility of autoantibodies in adult and juvenile myositis

(2013) Sarah L. Tansley et al.   CURRENT OPINION IN RHEUMATOLOGY

Classification, Diagnosis, and Management of Idiopathic Inflammatory Myopathies

(2013) I. N. Lazarou et al.   JOURNAL OF RHEUMATOLOGY

Autoantibodies in Polymyositis and Dermatomyositis

(2013) Anna Ghirardello et al.   Current Rheumatology Reports

Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort

(2012) Manabu Fujimoto et al.   ANNALS OF THE RHEUMATIC DISEASES

Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients

(2012) Yoshinao Muro et al.   AUTOIMMUNITY

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis

(2012) Karen E Smoyer-Tomic et al.   BMC MUSCULOSKELETAL DISORDERS

A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies

(2012) Neal F. Chaisson et al.   MEDICINE

Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody

(2012) Hua Cao et al.   ARTHRITIS CARE & RESEARCH

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

(2012) Angela Ceribelli et al.   ARTHRITIS RESEARCH & THERAPY

Morbidity and Mortality in Adult Polymyositis and Dermatomyositis

(2012) Isabelle Marie   Current Rheumatology Reports

Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment

(2012) Tsuneyo Mimori et al.   Current Rheumatology Reports

Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis

(2011) Yasuhito Hamaguchi et al.   ARCHIVES OF DERMATOLOGY

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy

(2011) Olivier Benveniste et al.   ARTHRITIS AND RHEUMATISM

Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

(2011) Manabu Fujimoto et al.   ARTHRITIS AND RHEUMATISM

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

(2011) David Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis

(2011) Andrew L. Mammen   Nature Reviews Neurology

Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan

(2011) Yoshinao Muro et al.   ARTHRITIS RESEARCH & THERAPY

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

(2010) Lisa Christopher-Stine et al.   ARTHRITIS AND RHEUMATISM

Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa Protein

(2009) G. ESPADA et al.   JOURNAL OF RHEUMATOLOGY

Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion

(2009) B. R. Whelan et al.   RHEUMATOLOGY

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

(2009) H. Gunawardena et al.   RHEUMATOLOGY

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

(2008) Z E Betteridge et al.   ANNALS OF THE RHEUMATIC DISEASES